HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,800 | -20.9% | 9,000 | +17.8% | 0.00% | -25.0% |
| Q4 2022 | $434,602 | +43.4% | 7,638 | -0.4% | 0.00% | +33.3% |
| Q3 2022 | $303,000 | -15.8% | 7,669 | -14.4% | 0.00% | -25.0% |
| Q4 2021 | $360,000 | +0.8% | 8,959 | +2.1% | 0.00% | +33.3% |
| Q3 2021 | $357,000 | -92.1% | 8,779 | -97.0% | 0.00% | -91.4% |
| Q3 2019 | $4,525,000 | -13.2% | 291,765 | -3.8% | 0.04% | -10.3% |
| Q2 2019 | $5,212,000 | -7.6% | 303,357 | -13.4% | 0.04% | -2.5% |
| Q1 2019 | $5,640,000 | +6.8% | 350,310 | -3.0% | 0.04% | -2.4% |
| Q4 2018 | $5,282,000 | +2.6% | 361,008 | +27.4% | 0.04% | +20.6% |
| Q3 2018 | $5,149,000 | +32.9% | 283,377 | +23.4% | 0.03% | +36.0% |
| Q2 2018 | $3,873,000 | -8.0% | 229,566 | +6.8% | 0.02% | -24.2% |
| Q1 2018 | $4,209,000 | +31.7% | 214,857 | +36.2% | 0.03% | +50.0% |
| Q4 2017 | $3,196,000 | +31.6% | 157,748 | +12.9% | 0.02% | +29.4% |
| Q3 2017 | $2,428,000 | +50.1% | 139,764 | +10.7% | 0.02% | +54.5% |
| Q2 2017 | $1,618,000 | +12.0% | 126,208 | +13.3% | 0.01% | +10.0% |
| Q1 2017 | $1,444,000 | +17.5% | 111,401 | -10.5% | 0.01% | +11.1% |
| Q4 2016 | $1,229,000 | -38.3% | 124,438 | -24.6% | 0.01% | -43.8% |
| Q3 2016 | $1,993,000 | +27.3% | 164,982 | -9.0% | 0.02% | +14.3% |
| Q2 2016 | $1,565,000 | +15.8% | 181,353 | +27.1% | 0.01% | 0.0% |
| Q1 2016 | $1,351,000 | -53.8% | 142,665 | -15.4% | 0.01% | -51.7% |
| Q4 2015 | $2,923,000 | -89.1% | 168,639 | -15.3% | 0.03% | +3.6% |
| Q3 2015 | $26,751,000 | +838.0% | 199,192 | +57.7% | 0.03% | +16.7% |
| Q2 2015 | $2,852,000 | +220.4% | 126,319 | +102.7% | 0.02% | +242.9% |
| Q1 2015 | $890,000 | – | 62,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |